Background-Intermittent rhythm monitoring (IRM) to detect atrial fibrillation (AF) recurrence is employed to evaluate the success of therapeutic interventions. In a large population of patients with continuous monitoring (CM), we investigated the sensitivity of various frequencies and durations of IRM strategies on the detection of AF recurrence, the dynamics behind AF recurrence detection, and we describe measures to evaluate temporal AF recurrence. Methods and Results-Rhythm histories of 647 patients (mean AF burden, 0.12Ϯ0.22; median, 0.014; 687 patient-years) with implantable CM devices were reconstructed and analyzed. With the use of computationally intensive simulation, the sensitivity of IRM of various frequencies and durations on the identification of AF recurrence was evaluated. Prolonged-duration IRM was superior to shorter IRM (PϽ0.0001). However, even with aggressive IRM strategies, AF recurrence was not detected in a great proportion of patients. The temporal AF burden aggregation (AF density) was directly related to IRM sensitivity (PϽ0.0001). Even at similar AF burdens, patients with high-density AF required higher-frequency or prolonged-duration IRM to achieve the same sensitivity as in low-density AF (PϽ0.0001). Patients with high-density, low-burden AF benefit the most from CM for detection of AF recurrence. Conclusions-IRM follow-up is significantly inferior to CM. IRM strategies will not identify AF recurrence in a great proportion of patients at risk. Temporal AF characteristics play a significant role in AF recurrence detection with the use of IRM. For the scientific, evidence-based evaluation of AF treatments, CM should be strongly recommended. Prospective studies are required to evaluate whether CM to guide clinical management can also improve patient outcomes. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00806689. (Circulation. 2012;126:806-814.)
D etection of atrial fibrillation (AF) recurrence after therapeutic interventions has until now been based primarily on the results of intermittent ("snapshot") rhythm monitoring (IRM). This approach has significant limitations in terms of sensitivity because the monitoring period of these examinations is limited; however, the results of these examinations are used to draw inferences on the success of ablation procedures or pharmacological strategies. It has been shown that reliance on symptoms or office ECGs overestimates the success rate of the ablation procedures and will misclassify patients who have recurrence of paroxysmal AF as being in sinus rhythm. [1] [2] [3] [4] The current consensus on AF monitoring recommends at least two 24-hour Holter monitor (HM) examinations annually for the detection of AF recurrence after ablation procedures, [5] [6] [7] which, however, has also been shown to underdetect AF recurrence and thus overestimate procedural success. 1, 8 Reliable and accurate detection of AF recurrence is thus of special importance for the evaluation of pharmacological or ablation therapies as well as when decisions on changes in anticoagulation or antiarrhythmic therapy are to be made. recently for more accurate detection of AF recurrence after ablation procedures or novel pharmacological strategies. 9 As expected, the sensitivity of these diagnostic modalities is close to 100% and, as such, is much superior to that of the currently employed 24-hour HM strategies. 8, 10 However, the implantation of a CM device in all patients may seem unrealistic. This led to the belief that intensifying noninvasive IRM either with greater frequency or with longer duration (7- or 30-day monitoring) or both may lead to better and more reliable detection of AF recurrence. 1, 11, 12 Recently, data from CM patients have been used to correlate the recurrence of AF with the risk for thromboembolic complications. [13] [14] [15] [16] The advance of this technology has not only provided better insight into the rhythm evaluation of these patients but has also initiated a change of mentality regarding AF from a qualitative ("yes/no") to a quantitative (amount of AF) approach. The AF burden, defined as the proportion of the total monitored time a patient is in AF, has been utilized in evaluating the risk for thromboembolism in patients with AF. [13] [14] [15] However, even these measures present a rather static approach in the evaluation of the dynamic incidence of AF recurrence, partially ignoring the temporal dispersion or temporal aggregation of the AF episodes and AF burden.
The aim of the present study was 2-fold: (1) to identify the sensitivity of IRM strategies of various frequencies and durations on the accurate detection of AF recurrence with the use of data collected from patients with heart rhythm CM devices and (2) to investigate the dynamics behind AF recurrence detection and propose measures to evaluate the temporal pattern of AF recurrence.
Methods
Data acquired from 647 patients monitored with a CM device (Reveal XT 9529, nϭ73; AT500 pacemaker, nϭ574; Medtronic, Inc, Minneapolis, MN) were analyzed. Demographics and patient characteristics are summarized in Table 1 . All patients provided informed consent for the data collection and use, and the study was approved by the local ethics committee.
With the use of data from the CM device, all AF episodes were examined. Isolated AF episodes of Ͻ5 minutes duration that could present artifacts were disregarded, and patients with no documented AF episode were regarded as AF free (nϭ174). The complete rhythm history of every patient was reconstructed ( Figure 1 ). Thereafter, we calculated the probability of successful identification of AF recurrence by IRM of various durations (eg, 24 hours and 7, 14, and 30 days) and frequencies for every patient. Computationally intensive simulation was employed to simulate in every patient all possible IRM strategies of various durations and frequencies to draw inferences on the sensitivity of the monitoring strategy and burden characteristics of the patients being monitored. Sensitivity was defined as the proportion of patients correctly identified as having AF recurrence with the simulated IRM strategy to the true number of patients having AF recurrence (identified from CM). AF burden was defined as the proportion of the time in AF in relation to the total monitored time. The simulation trials were performed as follows: After reconstructing the rhythm history of every patient j, monitored for a total of g days, we defined the sample space ⍀ kj ϭ{1, 2, …, g-kϩ1} to be the set of possible days that a k-day intermittent monitoring could be started (for kϭ1, 2, 7, 14, and 30). A k-day monitoring starting on day i ʦ ⍀ kj therefore included the following associated monitored days: i, iϩ1, …, iϩk-1. To simulate n independent k-day monitorings of patient j, n elements were selected at random from ⍀ kj , except that elements were rejected if their monitored days intersected with the monitored days of previously selected elements. AF was deemed to have been successfully identified if it was observed in at least 1 of the n sets of monitored days. This was performed for all patients of the study population, for monitoring durations of kϭ1, 2, 7, 14, and 30 days, and for strategies of nϭ1, 2, 3, …, 12 monitorings. The simulations were performed enough times (Ͼ50 000) to allow stabilization of the inferred parameter. All simulated IRM was of the continuous recording type. Randomization tests were used to compare sensitivities of prolonged IRM strategies with shorter IRM strategies and to compare patients with high and low AF densities. The P values of 2-sided tests are reported.
Using computationally intensive simulation, we sought to evaluate the inferences that can be drawn from a series of negative IRM on the patients' AF burden. Upper 90% confidence intervals for the AF burden of patients with a series of negative examinations for a given IRM strategy were found by performing Monte Carlo simulations of the strategy and evaluating the 90th percentile of AF burden among those patients with a series of negative examinations in their simulated monitorings.
With the complete rhythm history of every patient reconstructed, we evaluated measures to describe the AF recurrence and burden development over time, taking into consideration the temporal aggregation of the episodes and the temporal dispersion of the AF burden over the monitored period. For each patient, the course of the AF burden development over time throughout the monitored period was analyzed, and the minimum monitored time required for the development of each proportion of the patient's total observed AF burden throughout the monitored period was calculated (blue or red dotted line in Figure 2 , bottom). For example, in Figure 2 , patient C develops 50% of his total burden in 11% of the monitored time (black dot, patient C). Patient D, in contrast, required 40% of the observation time to develop 50% of his burden (black dot, patient D) as each day contributes less to the total burden because the AF burden is spread over more days. The black diagonal line (Figure 2 , patients C and D) represents a hypothetical uniform AF burden development (AF burden spread evenly throughout the monitoring period). As a measure of temporal AF burden aggregation, the cumulative deviation of the minimum monitored time required for the development of each proportion of the patient's total observed AF burden throughout the monitored period from a hypothetical uniform burden development (area between the actual [dotted line] and the uniform burden development curves [solid diagonal], Figure  2 ) was calculated (blue or red highlighted area, Figure 2 , bottom). This measurement was then scaled relative to the maximum possible burden aggregation for that specific patient's burden (ie, the complete burden as 1 continuous episode ["block of AF"]) to derive the burden density, an index taking values between 0 (meaning AF burden spread evenly over the observation time) and 1 (maximum possible AF burden aggregation [ie, "1 block/episode of AF"]).
For the numeric evaluation of the patient's AF density, we use the following definitions: For a patient with a total AF burden b, denote the minimum proportion of contiguous monitored time required for the development of a proportion p of the patient's total observed burden b as F(p;b). The absolute cumulative deviation of the patient's actual burden development from the hypothetical uniform burden development is evaluated as ͐ 0 1 ͉F͑ p;b͒Ϫp͉dp. When the burden b occurs with maximum temporal aggregation (ie, the complete burden as 1 continuous AF episode), the minimum time required for the development of 100% of the total burden is numerically equal to b, and the cumulative deviation from the hypothetical uniform burden development is 1Ϫb 2 . AF density is numerically evaluated as follows:
The detection probability gain of a CM versus an IRM strategy of k duration [with a probability of AF detection in patient i of Pr(k͉i)] was evaluated as 1ϪPr͑k͉i͒ Pr͑k͉i͒ and depicts the increase in probability of AF detection that CM offers in comparison to that of a random IRM of k duration (k: 24 hours, 7 days, 14 days, 30 days). Linear regression was used to determine whether AF burden and AF density were independently associated with the probability gain. To restore normality, the log of the probability gain was used as dependent variable.
The Mann-Whitney test was used for comparing AF burdens among patients with high and low density. All statistical analyses and procedures were performed with R version 2.14.1 (R Development Core Team; 2011; http://www.R-project.org/).
Results

Sensitivity of IRM
Quantitative AF characteristics are displayed in Figure 3 . Figure 4 displays the results for the sensitivity of random 24-hour and 7-, 14-, and 30-day monitorings at various frequencies to detect AF recurrence for the entire patient population. Prolonged IRM was significantly superior to shorter IRM (PϽ0.0001 for all comparisons). However, a four 24-hour HM strategy had a sensitivity of only 52%, thus failing to identify AF recurrence in almost half of the patients with proven AF recurrence. Even with a theoretical strategy of three 30-day HM tests (for a total monitoring duration of 90 days per year), the sensitivity did not exceed 82%, and thus a nonnegligible proportion of patients with AF would be misclassified ( Figure 4 ). However, the increased sensitivity offered by prolonged IRM durations comes at a cost of disproportionate increase in the required monitored time to achieve that level of sensitivity. For a sensitivity of 0.65, 30 days of monitoring would have been required with a 30-day 
Inferences Drawn From a Series of Negative IRM
Using computationally intensive simulation, we sought to evaluate the inferences that can be drawn from a series of negative IRM on the patients' AF burden. Although IRM strategies cannot determine the precise AF burden, reliable inferences can be obtained (for example, a patient with 4 negative random 30-day HM tests is highly unlikely to have a burden of Ͼ80%). These probabilities were derived from our patient population, taking into consideration not only the amount of AF in each patient but also the temporal characteristics of AF, and are displayed in Figure 5 . A series of 4 negative random 30-day HM tests suggests with 90% confidence that this patient's AF burden is Ͻ17%. Similarly, 8 negative 24-hour HM tests would be required to achieve the same level of confidence regarding the patient's AF burden. IRM of shorter duration requires a higher number of examinations to achieve the same level of confidence as IRM of longer durations ( Figure 5 ).
Influence of AF Burden and AF Density on Effectiveness on IRM
Using the reconstructed rhythm histories of our patients, we attempted to evaluate the quantitative as well as temporal AF characteristics that drive the sensitivity differences between IRM of various durations and frequencies. Burden density was directly related to the sensitivity of the different monitoring durations ( Figure 6 capture with the use of IRM than in patients with low-density AF, even at similar AF burdens. The superiority of CM in comparison to IRM was found to be significantly related to the AF burden and the AF density (Table 2 ). When CM is compared with 24-hour HM, the lower the AF burden and the higher the AF burden density, the greater is the gain from CM for AF recurrence detection (Figure 7 , left). Patients with low-burden, high-density AF profit the most from CM. When CM was compared with a 30-day HM strategy, the gain obtained with CM was also found to be significantly related to the AF density and the AF burden. The higher the AF density and the lower the AF burden, the higher is the detection probability gain from the CM strategy (Figure 7, right) .
Discussion
This study provides insights into the sensitivity of various monitoring strategies for the detection of AF recurrence with the use of data from a large patient population monitored with CM devices. Although 2 different monitoring devices were employed, AF detection in both devices was similar. The aim of our study was not to evaluate the AF detection process of the devices, which has been extensively validated previously, 10,17-19 but to evaluate the characteristics and dynamics of AF recurrence detection after AF episode registration.
Although this patient population presents an inhomogeneous collection of patients being monitored continuously with implantable devices, this gives us the opportunity to observe the characteristics of a very wide range of AF burden spectrum. The lower end of the AF burden spectrum is predominantly occupied by patients implanted with a CM device for monitoring after ablation procedures (mean AF burden, 0.05Ϯ0.16; median, 0.002; quartile 1, 0.001; quartile 3, 0.01) or patients with paroxysmal, asymptomatic AF, whereas the higher end of the spectrum is predominantly occupied by patients implanted with a pacemaker device for symptomatic bradyarrhythmia and long-lasting persistent AF. This wide range of AF burden observed allowed us to evaluate the sensitivity of the IRM strategies and evaluate the AF burden dynamics over a wide range of AF burdens.
Judgment of Therapeutic Success Based on IRM
Our group and other groups have previously evaluated sensitivity differences between IRM and CM by comparing the information obtained from CM devices with actual IRM performed in the same patients. 1, 4, 8, 11 However, these methods have limitations because the time point of the IRM plays a major role in the evaluation of these methods. As depicted in Figure 1 , in patient A, a 24-hour HM test performed at time point 1 will be negative and patient A will be regarded as "AF free," whereas the same examination performed some days earlier at time point 2 would have identified AF recurrence.
The results of such studies comparing continuous versus actual IRM are severely influenced by the choice of time points when the IRM is performed. Because in most of these studies only a limited number of IRM tests were compared to detect atrial fibrillation (AF) recurrence as a function of monitoring frequency (number of random monitorings) and monitoring duration (24 hours and 7, 14, and 30 days) in patients with proven AF recurrence. Only patients with documented AF recurrence were included. Prolonged IRM was significantly superior to shorter IRM (PϽ0.0001 for all comparisons). However, a four 24-hour Holter monitoring (HM) strategy had a sensitivity of only 52%, thus failing to identify AF recurrence in almost half of the patients with proven AF recurrence. The dotted horizontal line represents the sensitivity of 0.5 (fair coin). To achieve a sensitivity of 0.65 (solid horizontal line), 30 days of monitoring would have been required with a 30-day HM strategy (one 30-day HM test). To achieve the same sensitivity, 7 monitored days would have been required with a 24-hour HM strategy (seven 24-hour HM tests). The total number of monitored days required at the maximum frequency of each monitoring strategy is denoted. against CM, chance has an immeasurable effect on the results of such studies, and any inferences drawn from these results will be problematic. In the present study, the reconstruction of the rhythm history of every patient allows us to evaluate the true probability of AF recurrence detection of any random IRM of any duration in every patient, and computationally intensive simulation can draw inferences on the sensitivities and success rates of IRM of any duration and frequency. Figure 4 presents the results of this approach in our patient collective, depicting the sensitivities of the 4 most common IRM durations (24-hour and 7-, 14-, and 30-day HM) at various monitoring frequencies. In our patient population, a monitoring strategy with four 24-hour HM tests would have a sensitivity of only 52%, thus failing to identify recurrence of AF in almost half of these patients. This low sensitivity becomes even more striking if one considers that the flipping of a fair coin would have provided the same sensitivity for the detection of AF recurrence in these patients. The direct implication of these results is that the evaluation of pharmacological or interventional therapies when a 24-hour HM is employed as a monitoring strategy should be interpreted cautiously because a great proportion of patients will be misclassified, AF recurrence will be underdiagnosed, and therapeutic success will be overestimated. Similarly, a single, random 30-day HM in our patient population will have a sensitivity of 63%, and thus the evaluation of the success of an ablation procedure with the use of a single, postinterven-tional, 30-day HM would have a sensitivity of only 63% (slightly better than the sensitivity the flipping of a fair coin would provide). Even in the theoretical scenario of using three 30-day HM tests (for a total of 90 monitored days per year) would have a sensitivity of 82%; however, such a strategy seems unrealistic because it has been shown that complex or prolonged IRM strategies severely affect patient compliance. 7 To obtain the sensitivities of the various IRM strategies presented in this report, a 100% patient compliance is assumed; however, this is rarely the case in everyday clinical practice because even short-duration IRMs pose a significant compromise in the patients' quality of life, and this has been shown to lead to monitoring discontinuation. 7, 20 Roten et al 20 recently showed that even with mediumduration IRM (7-day HM), 42% of patients complained of discomfort and skin irritation, whereas 16% discontinued the monitoring because of this reason. On the other hand, the implantation of leadless CM requires a minor surgical procedure, and the device itself may carry a risk of infection or patient discomfort. Prolonged IRM strategies not only have reduced patient compliance but also offer diminished returns in terms of sensitivity gained per monitored day. The latter problem is depicted in Figure 4 . To achieve the same sensitivity (0.63; solid black horizontal line, Figure 4 ), 30 days of monitoring would have been required with a 30-day HM strategy (one 30-day HM test) versus only 7 days of monitoring with a 24-hour HM strategy (seven 24-hour HM tests). This disproportionate increase in required monitoring time to achieve a certain level of sensitivity between longand short-duration IRM would certainly have an impact on patient compliance with aggressive IRM strategies.
If the AF burden temporal characteristics are also taken into consideration (Figure 6 ), the detection of AF recurrence in patients with high-density AF becomes even more problematic. In the case of patients with high AF burden densities, a strategy of six 24-hour HM tests or one 30-day HM test would have been needed to provide a sensitivity of 50% (similar to that of a fair coin). In the low-density group, six 24-hour HM tests or one 30-day HM test would have provided a sensitivity of 0.72 and 0.86, respectively. Thus, patients with high-density AF require an even more aggressive IRM strategy to detect AF recurrence and evaluate results of therapeutic interventions. It becomes clear that with intermittent monitoring altogether, a great part or even the majority of patients will be misclassified, and therefore the scientific evaluation of therapeutic interventions for AF becomes problematic.
Semiquantitative Estimation of AF Burden Based on Negative IRM
Although IRM may fail to detect AF recurrence in a great proportion of patients and cannot provide the level of information a CM strategy does, results of serial IRM may guide patient management in a semiquantitative way when CM is not possible because of either limited availability, patient compliance, or cost considerations. Such an evaluation is depicted in Figure 5 . A series of negative IRM, although may underestimate qualitative AF detection per se, can however guide estimation of the potential AF burden level in patients prone to AF recurrence such as patients after ablation procedures, or patients on rhythm control strategies. In our large population of CM patients, 4 random negative 24-hour HM tests indicate, with a confidence of 90%, an AF burden of up to 23%. A higher number of serial negative IRM tests or negative IRM tests of greater duration can pinpoint the potential AF burden to lower levels. However, it is important to note that even average burdens that low have been shown to be a risk factor for thromboembolic complications. [13] [14] [15] [16] 21 
AF Characteristics Influencing the Success of IRM
A major variable driving the sensitivity in detecting AF recurrence is not only the AF burden but the dispersion of it over time. AF density, as a measure of this dispersion, proved to be a major factor that influences the sensitivity of IRM at various frequencies and durations. Although patients A and B of Figure 1 have very similar amounts of AF burden over the same observation time, the probability of AF recurrence detection is vastly different because of the different temporal AF burden dispersion. In patient B (Figure 1) , because of the even dispersion of AF burden, prolonged-duration IRM (30-day HM) is not superior to shorter-duration IRM (24hour HM), the probability of AF recurrence detection of both IRM tests is 1, and the sensitivity of both strategies is 100%. In patient A (Figure 1) , however, because of the high AF density, a random 30-day HM test offers only a negligible 3% increase in probability of AF recurrence detection compared with a random 24-hour HM test. In the whole patient cohort (Figure 6 ), the AF density appears to have a major and statistically significant influence on the sensitivity of AF detection with the use of IRM strategies. In patients with high-density AF, the probabilities of AF recurrence detection and the sensitivities of IRM strategies are significantly inferior to those of patients with same level of AF burden but low AF density ( Figure 6 ).
Implications for Clinical Outcomes, Patient Management, and Current Knowledge
Although the level of AF burden has been shown to be a significant risk factor for thromboembolic events, [13] [14] [15] [16] to the best of our knowledge, no study has taken into consideration the temporal characteristics of AF burden development. It is conceivable that the temporal distribution of AF burden may also play a role in the general thromboembolic risk that patients with AF face. Patients A and B (Figure 1 ), although spending the same time in AF, may have a different thromboembolic risk because of the different temporal distribution of their AF burden. Larger studies are required to evaluate this hypothesis, and prospective studies are required to evaluate the clinical impact of the combined quantitative and temporal AF characteristics on patient outcome.
The data presented may have some clinical implications. The results of our study depict the major limitations of IRM not only for management of patients but also for evaluation of the results of pharmacological as well as interventional therapies for AF. From a clinical perspective, accurate patient management can only be obtained with confidence with CM. From a scientific perspective, our evaluation until now of the success of pharmacological and interventional procedures based on IRM seems problematic in light of the results presented in this study. The accurate evaluation of therapies for AF in the era of evidence-based medicine mandates the use of CM.
It is conceivable that the widespread use of CM or the results from large studies of CM patients may require us to reevaluate our definitions of success or failure of therapeutic intervention for AF. It may very well be that the current definition of success of a therapeutic intervention only in terms of complete absence of AF recurrence might be inadequate and that a quantitative approach to AF recurrence may in the future require us to critically revisit our current knowledge and reevaluate our therapeutic interventions and . Gain in atrial fibrillation (AF) recurrence detection when using continuous monitoring versus 24-hour Holter monitoring (HM) (left) or 30-day HM (right) with respect to AF burden and burden density. Continuous monitoring offers significantly increased sensitivity in AF recurrence detection with a lower AF burden and a higher AF density ( Table 2 ). The gain obtained with continuous monitoring diminishes at burdens Ͼ0.4. AF burden density has been categorized into 3 categories (high, 0.6 -1; mid, 0.3-0.6; low, 0 -0.3).
strategies, our results, and our patient management decisionmaking process. Whether the use of CM to guide clinical management can also improve patient outcomes remains uncertain at this point and must be investigated in large randomized controlled prospective studies.
Limitations
This study was underpowered to investigate the clinical impact of temporal AF characteristics on patient outcomes. We believe that this should be the scope of large prospective studies or registries of CM patients over sufficient follow-up time. AF episodes of patients primarily implanted with a CM device because of atrial tachycardia or atrial flutter have been included in the analysis. In our experience, although patients are typically classified in 1 distinct rhythm type (atrial flutter, AF, or atrial tachycardia), CM reveals that these patients actually tend to experience multiple types of atrial rhythms. Although 2 different devices were employed in the population of this study, previous studies have extensively investigated the accuracy of AF detection of these devices (sensitivity, Ն98%; specificity, Ն91%). 10, 17, 18 Additionally, we tried to manually inspect all available episodes and, in cases of uncertainty or dispute, we discarded isolated, short (Ͻ5 minutes) episodes that could represent artifacts.
Conclusion
Patient follow-up with either short-or long-duration IRM is significantly inferior to CM for the detection of AF recurrence. IRM monitoring strategies will not identify AF recurrence in a great proportion of patients at risk. With shortduration, low-frequency IRM strategies, chance has an immeasurable effect on the evaluation of AF recurrence. Thus, results of pharmacological or invasive interventions evaluated with IRM should be considered with caution. Temporal AF characteristics play a major role in AF recurrence detection with the use of IRM strategies and may influence clinical parameters and outcomes in AF patients. For the scientific, evidence-based evaluation of AF treatments, CM should be strongly recommended.
